Exane Derivatives bought a new position in shares of Aramark (NYSE:ARMK) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 55,248 shares of the company’s stock, valued at approximately $2,264,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Comerica Bank purchased a new stake in shares of Aramark during the fourth quarter valued at approximately $408,000. Dimensional Fund Advisors LP increased its stake in shares of Aramark by 2.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,208,565 shares of the company’s stock valued at $43,172,000 after buying an additional 24,748 shares in the last quarter. UBS Asset Management Americas Inc. increased its stake in shares of Aramark by 17.9% in the fourth quarter. UBS Asset Management Americas Inc. now owns 569,559 shares of the company’s stock valued at $20,344,000 after buying an additional 86,342 shares in the last quarter. Highbridge Capital Management LLC bought a new position in Aramark during the fourth quarter valued at $17,579,000. Finally, Macquarie Group Ltd. raised its position in Aramark by 26.4% in the fourth quarter. Macquarie Group Ltd. now owns 145,608 shares of the company’s stock valued at $5,201,000 after buying an additional 30,424 shares during the last quarter. Institutional investors own 95.94% of the company’s stock.
Shares of Aramark (ARMK) opened at 39.35 on Friday. The stock has a market capitalization of $9.64 billion, a P/E ratio of 28.51 and a beta of 0.48. Aramark has a 52 week low of $32.73 and a 52 week high of $41.72. The company has a 50-day moving average of $40.33 and a 200-day moving average of $37.63.
Aramark (NYSE:ARMK) last issued its quarterly earnings results on Tuesday, August 8th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.35 by $0.05. The firm had revenue of $3.59 billion for the quarter, compared to analyst estimates of $3.61 billion. Aramark had a return on equity of 19.29% and a net margin of 2.37%. The business’s revenue was up .2% on a year-over-year basis. During the same period in the previous year, the company posted $0.34 earnings per share. On average, analysts anticipate that Aramark will post $1.96 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 5th. Stockholders of record on Wednesday, August 16th will be paid a $0.103 dividend. This represents a $0.41 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date is Monday, August 14th. Aramark’s dividend payout ratio is presently 29.93%.
TRADEMARK VIOLATION WARNING: This piece was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.com-unik.info/2017/08/12/exane-derivatives-acquires-shares-of-55248-aramark-armk-updated-updated-updated.html.
Several equities analysts recently weighed in on ARMK shares. BidaskClub upgraded shares of Aramark from a “hold” rating to a “buy” rating in a research report on Friday, June 16th. Zacks Investment Research upgraded shares of Aramark from a “hold” rating to a “buy” rating and set a $42.00 price target for the company in a research report on Friday, May 12th. Deutsche Bank AG increased their target price on shares of Aramark from $42.00 to $48.00 and gave the stock a “buy” rating in a research report on Wednesday, May 10th. Nomura reiterated a “buy” rating and set a $45.00 target price (up previously from $43.00) on shares of Aramark in a research report on Wednesday. Finally, Morgan Stanley increased their target price on shares of Aramark from $39.00 to $40.00 and gave the stock an “equal weight” rating in a research report on Thursday. One analyst has rated the stock with a sell rating, three have given a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $43.00.
In other Aramark news, EVP Stephen R. Reynolds sold 30,000 shares of the business’s stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of $40.41, for a total transaction of $1,212,300.00. Following the transaction, the executive vice president now owns 62,460 shares of the company’s stock, valued at $2,524,008.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Brian P. Pressler sold 10,629 shares of the business’s stock in a transaction on Friday, June 16th. The stock was sold at an average price of $40.80, for a total value of $433,663.20. Following the transaction, the senior vice president now directly owns 14,285 shares in the company, valued at approximately $582,828. The disclosure for this sale can be found here. Insiders sold 143,629 shares of company stock worth $5,618,413 over the last ninety days. Corporate insiders own 2.90% of the company’s stock.
Aramark Company Profile
Aramark is a global provider of food, facilities and uniform services to education, healthcare, business and industry, and sports, leisure and corrections clients. The Company operates through three segments: Food and Support Services North America (FSS North America), Food and Support Services International (FSS International), and Uniform and Career Apparel (Uniform).
What are top analysts saying about Aramark? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aramark and related companies.